Taro receives approval for generic bactroban ointment

Journal of Drugs in Dermatology, Jan, 2006

Taro Pharmaceutical Industries, Ltd., received FDA approval to market mupirocin, a generic version of GlaxoSmithKline's bactroban ointment. This ointment is commonly used to treat mild skin infections due to staphylococcus aureus.

COPYRIGHT 2006 Journal of Drugs in Dermatology, Inc.
COPYRIGHT 2008 Gale, Cengage Learning
 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
Click Here
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here

Content provided in partnership with Thompson Gale